Ieva Stirblytė

iPSC-Derived Platelets Depleted of HLA Class I Are Inert to Anti-HLA Class I and Natural Killer Cell Immunity

Daisuke Suzuki, Charlotte Flahou, Norihide Yoshikawa et al. · Stem Cell Reports · 2019 · 74 citations · Full text

Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells

Jūratė Savickienė, Gražina Treigytė, Giedrė Valiulienė et al. · Anti-Cancer Drugs · 2014 · 39 citations

Histone Modifications, Differentiation Therapy, Chemoprevention Strategy +19

Euchromatic histone methyltransferase 2 inhibitor, BIX-01294, sensitizes human promyelocytic leukemia HL-60 and NB4 cells to growth inhibition and differentiation

Jūratė Savickienė, Gražina Treigytė, Ieva Stirblytė et al. · Leukemia Research · 2014 · 32 citations

Histone Modifications, Tumor Biology, Chromatin +12

Belinostat, a potent <scp>HDAC</scp>i, exerts antileukaemic effect in human acute promyelocytic leukaemia cells <i>via</i> chromatin remodelling

Giedrė Valiulienė, Ieva Stirblytė, Dovile Cicenaite et al. · Journal of Cellular and Molecular Medicine · 2015 · 29 citations · Full text

Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells

Giedrė Valiulienė, Ieva Stirblytė, Monika Jasnauskaitė et al. · European Journal of Pharmacology · 2017 · 27 citations

Hematological Malignancy, Medicine, Malignant Blood Disorder +11